Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

GLUCGlucose Health, Inc.

OTC · CIK 0001420108
Filer categorySmaller reporting company
Entity typeoperating
SIC2833 Medicinal Chemicals & Botanical Products
FY end1231
XBRL facts160

Identity from submissions API

NameGlucose Health, Inc.
CIK0001420108
TickersGLUC
ExchangesOTC
Entity typeoperating
CategorySmaller reporting company
SIC2833 Medicinal Chemicals & Botanical Products
EIN901117742
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone479-802-3827
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Bio-Solutions Corp. (2007-12-07T00:00:00.000Z → 2014-12-16T00:00:00.000Z)
Business address
609 SW 8TH STREET, SUITE 600
BENTONVILLE
AR
72712
AR
Mailing address
609 SW 8TH STREET, SUITE 600
BENTONVILLE
AR
72712
AR

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

140 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-10-19 D xslFormDX01/primary_doc.xml 06b 0001420108-26-000007 021-601719 261468587 33 9509
2026-10-07 D xslFormDX01/primary_doc.xml 06b 0001420108-26-000006 021-600381 261447753 33 9328
2026-10-06 D xslFormDX01/primary_doc.xml 06b 0001420108-26-000005 021-600102 261443627 33 9314
2026-10-06 D xslFormDX01/primary_doc.xml 06b 0001420108-26-000004 021-600098 261443586 33 9424
2026-09-10 D xslFormDX01/primary_doc.xml 06b 0001420108-26-000003 021-597074 261371856 33 9218
2026-07-07 D xslFormDX01/primary_doc.xml 06b 0001420108-26-000002 021-589791 261158925 33 8766
2026-02-04 D xslFormDX01/primary_doc.xml 06b 0001420108-26-000001 021-572404 26598651 33 8826
2025-12-05 D xslFormDX01/primary_doc.xml 06b 0001420108-25-000002 021-565982 251553539 33 9601
2024-01-19 D/A xslFormDX01/primary_doc.xml 06b 0001477932-24-000270 021-499069 24543484 33 5978
2023-12-07 D xslFormDX01/primary_doc.xml 06b 0001477932-23-009018 021-499069 231472095 33 5835
2023-06-28 RW RW 0001477932-23-004855 333-265335 231051113 NE 8214
2023-01-09 S-1/A FORM S-1/A 0001477932-23-000175 333-265335 23516481 33 7321643 1 1
2022-09-06 S-1/A FORM S-1/A 0001477932-22-006657 333-265335 221226632 33 6217257 1 1
2022-08-05 S-1/A FORM S-1/A 0001477932-22-005660 333-265335 221138525 33 5989452 1 1
2022-06-01 S-1 FORM S-1 0001477932-22-004038 333-265335 22985362 33 18452087 1 1
2021-03-09 D xslFormDX01/primary_doc.xml 06b 0001477932-21-001334 021-391678 21726235 33 7991
2020-06-19 D xslFormDX01/primary_doc.xml 06b 0001477932-20-003466 021-369359 20975498 33 7986
2020-05-12 D xslFormDX01/primary_doc.xml 06b 0001477932-20-002548 021-366749 20868685 33 5788
2019-05-03 D xslFormDX01/primary_doc.xml 06b 0001477932-19-002298 021-338746 19794426 33 5825
2018-04-16 15-12G FORM 15-12G 0001477932-18-001817 000-55439 18756653 34 6067
2018-04-02 NT 10-K NT 10-K 0001477932-18-001620 000-55439 18728818 34 16271
2017-11-14 10-Q FORM 10-Q 0001477932-17-005517 000-55439 171198115 34 1542584 1
2017-08-21 10-Q FORM 10-Q 0001477932-17-004075 000-55439 171042080 34 1422895 1
2017-08-14 NT 10-Q NT 10-Q 0001477932-17-003940 000-55439 171029989 34 18891
2017-05-15 10-Q FORM 10-Q 0001477932-17-002253 000-55439 17842566 34 1295072 1
2017-04-11 8-K FORM 8-K 4.01,9.01 0001477932-17-001658 000-55439 17755994 34 31290
2017-03-29 10-K FORM 10-K 0001477932-17-001354 000-55439 17720063 34 1945070 1
2016-12-21 10-Q FORM 10-Q 0001477932-16-014204 000-55439 162063657 34 1233006 1
2016-11-14 NT 10-Q NT 10-Q 0001477932-16-013435 000-55439 161993614 34 20658
2016-08-22 10-Q FORM 10-Q 0001477932-16-012202 000-55439 161845992 34 1125760 1
2016-08-15 NT 10-Q NT 10-Q 0001477932-16-011888 000-55439 161832462 34 18327
2016-05-23 10-Q FORM 10-Q 0001477932-16-010562 000-55439 161669279 34 1086027 1
2016-05-16 NT 10-Q NT 10-Q 0001477932-16-010329 000-55439 161652131 34 17944
2016-04-14 10-K FORM 10-K 0001477932-16-009786 000-55439 161572553 34 2030843 1
2016-03-30 NT 10-K NT 10-K 0001477932-16-009323 000-55439 161539528 34 18287
2016-03-11 8-K FORM 8-K 8.01 0001477932-16-009009 000-55439 161500705 34 11085
2016-02-05 8-K FORM 8-K 5.02 0001477932-16-008445 000-55439 161392497 34 11299
2016-01-27 8-K FORM 8-K 8.01 0001477932-16-008299 000-55439 161364068 34 10069
2015-11-23 10-Q FORM 10-Q 0001477932-15-007294 000-55439 151248224 34 1252684 1
2015-11-16 NT 10-Q NT 10-Q 0001477932-15-006962 000-55439 151231464 34 19774
2015-08-18 10-Q FORM 10-Q 0001477932-15-005379 000-55439 151062219 34 1259748 1
2015-08-14 NT 10-Q NT 10-Q 0001477932-15-005162 000-55439 151054284 34 20307
2015-08-06 8-K FORM 8-K 4.01,9.01 0001477932-15-004880 000-55439 151030396 34 33014
2015-05-19 10-Q FORM 10-Q 0001477932-15-003358 000-55439 15874698 34 1501488 1
2015-05-15 NT 10-Q NT 10-Q 0001477932-15-003281 000-55439 15869338 34 19913
2015-05-08 3 OWNERSHIP DOCUMENT FORM TYPE 3 0001554795-15-000171 4332
2015-05-01 8-A12G 8-A12G 0001477932-15-002847 000-55439 15823533 34 13073
2015-03-30 10-K FORM 10-K 0001477932-15-001981 333-147917 15734494 34 3072744 1
2015-02-12 8-K FORM 8-K 5.02 0001477932-15-001093 333-147917 15602470 34 10033
2014-12-16 8-K FORM 8-K 8.01,9.01 0001477932-14-007105 333-147917 141289752 34 16404
2014-11-10 8-K FORM 8-K 5.03,9.01 0001477932-14-005937 333-147917 141208992 34 1580247
2014-10-23 8-K/A FORM 8-K/A 1.01,3.02,5.01,5.02,9.01 0001477932-14-005595 333-147917 141168678 34 18746
2014-10-22 10-Q FORM 10-Q 0001477932-14-005534 333-147917 141166773 34 3165132 1
2014-10-07 8-K FORM 8-K 4.01,9.01 0001477932-14-005286 333-147917 141145239 34 39579
2014-10-02 8-K FORM 8-K 1.01,5.02,9.01 0001477932-14-005243 333-147917 141135680 34 44906
2014-08-12 10-Q FORM 10-Q 0001477932-14-004205 333-147917 141032892 34 3233700 1
2014-07-25 8-K FORM 8-K 5.02,9.01 0001477932-14-003877 333-147917 14992593 34 27685
2014-07-16 10-Q FORM 10-Q 0001477932-14-003731 333-147917 14977950 34 3484481 1
2014-07-01 UPLOAD filename1.pdf 0000000000-14-033261 36594
2014-06-25 10-K FORM 10-K 0001477932-14-003318 333-147917 14940077 34 4642005 1
2014-05-05 8-K FORM 8-K 4.01,9.01 0001477932-14-002331 333-147917 14811262 34 51909
2014-05-05 10-K/A FORM 10-K/A 0001477932-14-002329 333-147917 14811258 34 3008074 1
2014-04-24 10-K/A FORM 10-K/A 0001477932-14-001939 333-147917 14781543 34 1244252
2014-04-23 8-K FORM 8-K 5.02 0001477932-14-001911 333-147917 14777387 34 21791
2014-04-15 8-K FORM 8-K 1.01,1.02,5.02,5.03,9.01 0001477932-14-001755 333-147917 14763990 34 6037173
2014-03-31 NT 10-K NT 10-K 0001477932-14-001340 333-147917 14727743 34 40900
2014-03-19 CORRESP filename1.htm 0001477932-14-001135 118845
2014-03-06 UPLOAD filename1.pdf 0000000000-14-011340 43232
2014-02-25 CORRESP filename1.htm 0001477932-14-000843 834919
2014-01-28 CORRESP filename1.htm 0001477932-14-000404 24621
2014-01-14 UPLOAD filename1.pdf 0000000000-14-001876 164238
2014-01-02 CORRESP filename1.htm 0001477932-14-000004 587521
2013-12-18 UPLOAD filename1.pdf 0000000000-13-068591 164474
2013-12-04 CORRESP filename1.htm 0001477932-13-005930 270091
2013-11-20 UPLOAD filename1.pdf 0000000000-13-063739 167430
2013-11-14 10-Q FORM 10-Q 0001477932-13-005415 333-147917 131216712 34 2268969 1
2013-08-06 8-K FORM 8-K 1.01,9.01 0001477932-13-003492 333-147917 131012988 34 3798012
2013-08-02 10-Q FORM 10-Q 0001477932-13-003445 333-147917 131004804 34 3308759 1
2013-05-06 10-Q FORM 10-Q 0001477932-13-002137 333-147917 13814576 34 1784968 1
2013-03-22 10-K FORM 10-K 0001477932-13-001273 333-147917 13709899 34 3133731 1
2013-03-04 S-8 BIO-SOLUTIONS CORP. FORM S-8 0001566506-13-000012 333-187038 13662747 33 236962
2012-11-14 10-Q bisu10q930.htm 0001471242-12-001449 333-147917 121203106 34 2126681 1
2012-09-05 10-Q/A bio-solutions10qa063012.htm 0001432093-12-000697 333-147917 121072971 34 56226
2012-08-31 10-Q/A biosolutions10qa063012.htm 0001432093-12-000689 333-147917 121068325 34 1672006 1
2012-08-13 10-Q biosolutions10q063012.htm 0001432093-12-000611 333-147917 121027017 34 524970
2012-07-25 10-Q bio-solutions10q033112.htm 0001432093-12-000578 333-147917 12978055 34 1528054 1
2012-06-26 8-K bio-solutions8k062012.htm 5.02,9.01 0001432093-12-000499 333-147917 12925553 34 26133
2012-05-31 10-K bio-solutions10k123111.htm 0001214782-12-000044 333-147917 12880473 34 2286161 1
2012-03-29 NT 10-K bio-solutionsnt10k123111.htm 0001432093-12-000188 333-147917 12723927 34 24820
2012-02-27 8-K biosolutions8k021512.htm 5.02,9.01 0001214782-12-000015 333-147917 12641079 34 26261
2011-11-22 8-K BIO-SOLUTIONS, CORP. FORM 8-K FOR SEPTEMBER 26, 2011 1.01,2.01,9.01 0001214782-11-000198 333-147917 111220351 34 917263
2011-11-21 10-Q biosolutions10q093011.htm 0001214782-11-000191 333-147917 111218026 34 1446917 1
2011-11-16 8-K biosolutiions8k101011.htm 5.02,9.01 0001214782-11-000184 333-147917 111208896 34 30886
2011-11-14 NT 10-Q bio-solutionsnt10q093011.htm 0001214782-11-000167 333-147917 111198557 34 25070
2011-10-27 UPLOAD filename1.pdf 0000000000-11-062774 45414
2011-09-29 10-K/A f12312010kafinal.htm 0001096350-11-000147 333-147917 111113050 34 471300
2011-09-28 CORRESP filename1.htm 0001096350-11-000148 8530
2011-09-28 10-Q/A tenqa.htm 0001096350-11-000145 333-147917 111112963 34 1017780 1
2011-09-20 UPLOAD filename1.pdf 0000000000-11-055885 59154
2011-08-22 10-Q tenq.htm 0001096350-11-000114 333-147917 111049594 34 218775
2011-08-12 NT 10-Q form12b25_extension.htm 0001096350-11-000111 333-147917 111032076 34 14576
2011-05-23 10-Q tenq.htm 0001096350-11-000083 333-147917 11865271 34 305771
2011-05-23 10-Q tenq.htm 0001096350-11-000082 333-147917 11865037 34 305771
2011-05-16 NT 10-Q late.htm 0001096350-11-000075 333-147917 11844020 34 14027
2011-04-20 10-K/A tenka.htm 0001096350-11-000067 333-147917 11769862 34 450252
2011-04-14 10-K f12312010k.htm 0001096350-11-000063 333-147917 11759805 34 429947
2011-03-31 NT 10-K late.htm 0001096350-11-000060 333-147917 11725081 34 13819
2011-03-29 S-8 s8.htm 0001096350-11-000057 333-173152 11719618 33 159120
2010-11-22 10-Q QUARTERLY REPORT ON FORM 10-Q 0001469299-10-000355 333-147917 101209454 34 492070
2010-11-15 NT 10-Q BIO-SOLUTIONS FORM 12B25 093010 0001469299-10-000346 333-147917 101192522 34 34815
2010-08-13 10-Q BIO-SOLUTIONS FORM 10-Q 063010 0001469299-10-000238 333-147917 101014688 34 494707
2010-06-25 8-K BIO-SOLUTIONS FORM 8-K 06/25/10 7.01,8.01,9.01 0001469299-10-000188 333-147917 10917726 34 123310
2010-05-17 10-Q BIO-SOLUTIONS FORM 10-Q 03/31/10 0001469299-10-000163 333-147917 10838304 34 448278
2010-04-15 10-K BIO-SOLUTIONS FORM 10-K 123109 0001469299-10-000114 333-147917 10753012 34 789401
2010-03-31 NT 10-K BIO-SOLUTIONS FORM 12B25 12/31/09 0001469299-10-000089 333-147917 10718858 34 29978
2009-11-16 10-Q BIO-SOL FORM 10Q 09/30/09 0001469299-09-000040 333-147917 091186011 34 449217
2009-08-18 8-K BIO-SOLUTIONS FORM 8-K 081709 1.01 0001469299-09-000019 333-147917 091021764 34 106466
2009-08-14 10-Q BIO-SOLUTIONS FORM10-Q 063009 0001469299-09-000015 333-147917 091014124 34 508260
2009-05-14 10-Q BIO SOLUTIONS FORM 10-Q 033109 0001402973-09-000048 333-147917 09827621 34 453651
2009-05-12 424B3 BIO SOLUTIONS FORM 424B3 051109 0001402973-09-000042 333-158129 09818990 33 810781
2009-05-06 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2009-05-06 16:00:00 9999999995-09-001316 333-158129 09803346 33 2079
2009-05-04 CORRESP filename1.htm 0001402973-09-000038 11419
2009-04-24 UPLOAD filename1.pdf 0000000000-09-021815 72564
2009-04-23 CORRESP filename1.htm 0001402973-09-000036 23246
2009-04-23 S-1/A BIO SOLUTIONS FORM S-1/A 042209 0001402973-09-000035 333-158129 09766062 33 856885
2009-04-23 10-K/A BIO SOLUTIONS FORM 10-K/A 12/31/08 0001402973-09-000034 333-147917 09766059 34 98233
2009-03-20 S-1 BIO SOLUTIONS FORM S-1 031809 0001402973-09-000020 333-158129 09696900 33 855046
2009-03-18 8-K BIO SOLUTIONS FORM 8-K 031709 5.02,9.01 0001402973-09-000013 333-147917 09691690 34 28837
2009-03-16 10-K BIO-SOLUTIONS FORM 10-K FOR THE PERIOD DECEMBER 31, 2008 0001402973-09-000011 333-147917 09683546 34 780667
2008-12-23 8-K BIO SOLUTIONS FORM 8-K 121808 3.02 0001402973-08-000081 333-147917 081267543 34 25853
2008-11-14 10-Q BIO SOLUTIONS FORM 10Q 093008 0001402973-08-000064 333-147917 081191992 34 483263
2008-09-16 8-K BIO-SOL CORP FORM 8-K 090308 1.01,2.03,5.06,9.01 0001402973-08-000059 333-147917 081074789 34 156904
2008-08-13 10-Q BIO-SOLUTIONS CORP. FORM 10-Q FOR THE PERIOD JUNE, 30 2008 0001402973-08-000052 333-147917 081013277 34 462288
2008-05-09 10-Q BIO-SOLUTIONS CORP. FORM 10-Q FOR THE PERIOD ENDING MARCH 31, 2008 0001402973-08-000037 333-147917 08815476 34 411871
2008-04-10 10KSB BIO-SOLUTIONS FORM 10-KSB FOR THE PERIOD DECEMBER 31, 2007 0001402973-08-000033 333-147917 08750218 34 534350
2008-04-01 NT 10-K BIO-SOLUTIONS CORP. FORM NT 10-K FOR THE PERIOD 12/31/07 0001402973-08-000031 333-147917 08728393 34 52785
2008-02-01 8-K BIO-SOLUTIONS CORP. FORM 8-K JANUARY 29, 2008 4.01,9.01 0001402973-08-000018 333-147917 08565916 34 43055
2007-12-28 424B3 BIO-SOLUTIONS CORP. 424(B)(3) DECEMBER 26, 2007 0001402973-07-000031 333-147917 071331500 33 783982
2007-12-21 EFFECT xslEFFECTX01/primary_doc.xml SB-2,,2007-12-21 14:00:00 9999999995-07-005068 333-147917 071324772 33 2081
2007-12-07 SB-2 BIO-SOLUTIONS CORP. FORM SB-2 0001402973-07-000026 333-147917 071291327 33 1003004

Latest XBRL company facts

One latest value per concept from companyfacts (160 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 4.55M 2017-11-14 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
dei EntityPublicFloat Entity Public Float USD 78,485 2016-06-30 2016 FY 10-K 2017-03-29 0001477932-17-001354
us-gaap AccountsPayable Accounts Payable (Deprecated 2009-01-31) USD 384,509 2010-12-31 2011 Q2 10-Q/A 2011-09-28 0001096350-11-000145
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 78,279 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 9,105 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 41,429 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts Accumulated Amortization, Debt Issuance Costs, Noncurrent USD 105 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap AccumulatedOtherComprehensiveIncomeLossBeforeTax Accumulated Other Comprehensive Income (Loss), before Tax (Deprecated 2009-01-31) USD -68,019 2010-12-31 2011 Q2 10-Q/A 2011-09-28 0001096350-11-000145
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -75,278 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 120,000 2016-12-31 2016 FY 10-K 2017-03-29 0001477932-17-001354
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 5.72M 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities USD -52,924 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 73,748 2011-10-01 2011-12-31 2011 FY 10-K 2012-05-31 0001214782-12-000044
us-gaap AdvertisingExpense Advertising Expense USD 5,437 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap AmortizationExpensePerDollarOfGrossRevenue Amortization Expense Per Dollar of Gross Revenue USD 24,167 2010-06-30 2011 Q2 10-Q/A 2011-09-28 0001096350-11-000145
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 201,902 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 45 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 200,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-30 0001477932-15-001981
us-gaap Assets Assets USD 26,353 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap AssetsCurrent Assets, Current USD 26,158 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap Cash Cash USD 23,639 2016-09-30 2016 Q3 10-Q 2016-12-21 0001477932-16-014204
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 16,636 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -3,906 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 16,636 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap CommonStockAdditionalSeriesSharesAuthorized Common Stock, Additional Series, Shares Authorized (Deprecated 2009-01-31) shares 90.00M 2010-06-30 2012 FY 10-K 2013-03-22 0001477932-13-001273
us-gaap CommonStockAdditionalSeriesSharesIssued Common Stock, Additional Series, Shares, Issued (Deprecated 2009-01-31) shares 251,050 2010-06-30 2011 Q2 10-Q/A 2011-09-28 0001096350-11-000145
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0.015 2013-06-18 2013 Q3 10-Q 2013-11-14 0001477932-13-005415
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 4.52M 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 4.52M 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap CommonStockSharesSubscriptions Common Stock, Value, Subscriptions USD 23,000 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable USD 1,520 2011-09-30 2011 Q3 10-Q 2011-11-21 0001214782-11-000191
us-gaap CommonStockValue Common Stock, Value, Issued USD 4,516 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -2.09M 2011-10-01 2014-03-31 2014 Q1 10-Q 2014-07-16 0001477932-14-003731
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 159,220 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 112,157 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 279,258 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-12-21 0001477932-16-014204
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 3,632 2011-10-01 2012-12-31 2012 FY 10-K/A 2014-05-05 0001477932-14-002329
us-gaap CostOfRevenue Cost of Revenue USD 15,700 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 29,291 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD -10,436 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-29 0001477932-17-001354
us-gaap DebtCurrent Debt, Current USD 169,923 2014-12-31 2014 FY 10-K 2015-03-30 0001477932-15-001981
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 109,541 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-29 0001477932-17-001354
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 0.007 2012-07-31 2012 Q2 10-Q/A 2012-08-31 0001432093-12-000689
us-gaap DebtInstrumentConvertibleNumberOfEquityInstruments Debt Instrument, Convertible, Number of Equity Instruments shares 14.53M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001471242-12-001449
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 30,000 2012-07-31 2012 Q2 10-Q/A 2012-08-31 0001432093-12-000689
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 0 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.05 2012-12-31 2012 FY 10-K/A 2014-05-05 0001477932-14-002329
us-gaap DeferredCompensationLiabilityCurrent Deferred Compensation Liability, Current USD -17,372 2013-12-31 2014 FY 10-K 2015-03-30 0001477932-15-001981
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -2.06M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-29 0001477932-17-001354
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -2.06M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-29 0001477932-17-001354
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 2.07M 2014-03-31 2014 Q1 10-Q 2014-07-16 0001477932-14-003731
us-gaap DueFromAffiliates Due from Affiliates USD 250 2015-12-31 2016 FY 10-K 2017-03-29 0001477932-17-001354
us-gaap DueToOfficersOrStockholders Due to Officers or Stockholders (Deprecated 2009-01-31) USD 4,858 2010-12-31 2011 Q2 10-Q/A 2011-09-28 0001096350-11-000145
us-gaap DueToOfficersOrStockholdersCurrent Due to Officers or Stockholders, Current USD 4,751 2011-12-31 2012 FY 10-K/A 2014-05-05 0001477932-14-002329
us-gaap DueToOtherRelatedPartiesClassifiedCurrent Due to Other Related Parties, Current USD 9,000 2012-09-30 2012 Q3 10-Q 2012-11-14 0001471242-12-001449
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 1,672 2013-12-31 2014 FY 10-K 2015-03-30 0001477932-15-001981
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.01 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure -0.34 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-29 0001477932-17-001354
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-29 0001477932-17-001354
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 5,507 2011-10-01 2014-03-31 2014 Q1 10-Q 2014-07-16 0001477932-14-003731
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 1.971 2014-01-01 2014-12-31 2015 FY 10-K 2016-04-14 0001477932-16-009786
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.009 2014-01-01 2014-12-31 2015 FY 10-K 2016-04-14 0001477932-16-009786
us-gaap FiniteLivedIntangibleAssetsAcquired Finite-lived Intangible Assets Acquired (Deprecated 2013-01-31) USD 141,525 2008-09-11 2011-09-11 2012 Q3 10-Q 2012-11-14 0001471242-12-001449
us-gaap GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness Gain (Loss) on Components Excluded from Assessment of Foreign Currency Cash Flow Hedge Effectiveness USD -807 2011-01-30 2011-06-30 2011 Q2 10-Q/A 2011-09-28 0001096350-11-000145
us-gaap GainLossOnNonRecourseDebt Gain (Loss) on Non-Recourse Debt USD 14,562 2014-01-01 2014-12-31 2015 FY 10-K 2016-04-14 0001477932-16-009786
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -21,000 2013-01-01 2013-09-30 2014 Q3 10-Q 2014-10-22 0001477932-14-005534
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 24,741 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap GrossProfit Gross Profit USD 57,240 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap GroundLeasesAccumulatedAmortization Ground Leases, Accumulated Amortization USD 75 2017-03-31 2017 Q1 10-Q 2017-05-15 0001477932-17-002253
us-gaap ImpairedFinancingReceivableUnpaidPrincipalBalance Impaired Financing Receivable, Unpaid Principal Balance USD 6,000 2013-12-31 2013 FY 10-K 2014-06-25 0001477932-14-003318
us-gaap ImpairmentChargeOnReclassifiedAssets Impairment Charge on Reclassified Assets USD 20,829 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-30 0001477932-15-001981
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 34,967 2010-01-01 2010-12-31 2012 Q3 10-Q 2012-11-14 0001471242-12-001449
us-gaap ImpairmentOfInvestments Other than Temporary Impairment Losses, Investments USD 200,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-30 0001477932-15-001981
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 39,018 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -58,131 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 1,416 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -221 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -1,952 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap IncreaseDecreaseInInventoryForLongTermContractsOrPrograms Increase (Decrease) in Inventory for Long-term Contracts or Programs USD -4,125 2010-01-30 2010-06-30 2011 Q2 10-Q/A 2011-09-28 0001096350-11-000145
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 531 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 195 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap InterestExpense Interest Expense USD 11,512 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 1,499 2010-01-01 2010-09-30 2011 Q3 10-Q 2011-11-21 0001214782-11-000191
us-gaap InterestPayableCurrent Interest Payable, Current USD 33,081 2016-09-30 2016 Q3 10-Q 2016-12-21 0001477932-16-014204
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 87,758 2010-12-31 2012 FY 10-K/A 2014-05-05 0001477932-14-002329
us-gaap InventoryNet Inventory, Net USD 0 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap InventoryWriteDown Inventory Write-down USD 14,402 2014-01-01 2014-12-31 2015 FY 10-K 2016-04-14 0001477932-16-009786
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 1,875 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-29 0001477932-17-001354
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 0 2012-01-01 2012-12-31 2012 FY 10-K/A 2014-05-05 0001477932-14-002329
us-gaap Liabilities Liabilities USD 452,585 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 26,353 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap LiabilitiesCurrent Liabilities, Current USD 452,585 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 10,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 250 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-29 0001477932-17-001354
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -13,906 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 39,018 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 46,619 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap NotesIssued1 Notes Issued USD 294,722 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-29 0001477932-17-001354
us-gaap NotesPayableCurrent Notes Payable, Current USD 10,000 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 35,000 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap NumberOfReportingUnits Number of Reporting Units Unit 4,927 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap OperatingExpenses Operating Expenses USD 64,841 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -7,601 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 6.24M 2016-12-31 2016 FY 10-K 2017-03-29 0001477932-17-001354
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 200,000 2013-01-01 2013-12-31 2014 Q3 10-Q 2014-10-22 0001477932-14-005534
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD -12,578 2011-10-01 2014-03-31 2014 Q1 10-Q 2014-07-16 0001477932-14-003731
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-06-25 0001477932-14-003318
us-gaap OtherExpenses Other Expenses USD -10,537 2011-01-31 2011-06-30 2011 Q2 10-Q/A 2011-09-28 0001096350-11-000145
us-gaap OtherIntangibleAssetsNet Other Intangible Assets, Net USD 200,000 2014-09-30 2014 Q3 10-Q 2014-10-22 0001477932-14-005534
us-gaap OtherNoncashIncome Other Noncash Income USD 20,573 2015-01-01 2015-09-30 2016 Q3 10-Q 2016-12-21 0001477932-16-014204
us-gaap OtherNotesPayableCurrent Other Notes Payable, Current USD 16,500 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap OtherSalesRevenueNet Other Revenue, Net (Deprecated 2018-01-31) USD 20,829 2014-01-01 2014-12-31 2015 FY 10-K 2016-04-14 0001477932-16-009786
us-gaap OtherSignificantNoncashTransactionValueOfConsiderationGiven1 Other Significant Noncash Transaction, Value of Consideration Given USD 291,559 2011-10-01 2013-12-31 2013 FY 10-K 2014-06-25 0001477932-14-003318
us-gaap PaymentsForAdvanceToAffiliate Payments for Advance to Affiliate USD 250 2015-01-01 2015-09-30 2016 Q3 10-Q 2016-12-21 0001477932-16-014204
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets CAD 50,000 2008-09-11 2011-09-11 2012 Q3 10-Q 2012-11-14 0001471242-12-001449
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1,000 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 1,000 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 1,000 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 113,200 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 417 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 11,480 2011-01-01 2011-12-31 2012 FY 10-K/A 2014-05-05 0001477932-14-002329
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 33,500 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap ProceedsFromRepaymentsOfOtherDebt Proceeds from (Repayments of) Other Debt USD 76,850 2011-10-01 2012-12-31 2012 FY 10-K/A 2014-05-05 0001477932-14-002329
us-gaap ProceedsFromRepaymentsOfShortTermDebt Proceeds from (Repayments of) Short-term Debt USD -1,387 2011-10-01 2012-12-31 2012 FY 10-K/A 2014-05-05 0001477932-14-002329
us-gaap ProductionRelatedImpairmentsOrCharges Production Related Impairments or Charges USD 200,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-06-25 0001477932-14-003318
us-gaap ProfessionalFees Professional Fees USD 39,194 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -1.46M 2013-01-01 2013-12-31 2013 FY 10-K 2014-06-25 0001477932-14-003318
us-gaap PropertyPlantAndEquipmentSalvageValue Property, Plant, and Equipment, Salvage Value USD 225 2017-03-31 2017 Q1 10-Q 2017-05-15 0001477932-17-002253
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 23,500 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 48 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-29 0001477932-17-001354
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -6.21M 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap SalariesAndWages Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold USD 504,192 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-30 0001477932-15-001981
us-gaap SaleLeasebackTransactionHistoricalCost Sale Leaseback Transaction, Historical Cost USD 300 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 0.018 2013-12-31 2014 Q3 10-Q 2014-10-22 0001477932-14-005534
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 72,940 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 906 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 20.00M 2011-03-31 2012 Q2 10-Q/A 2012-08-31 0001432093-12-000689
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 15.47M 2011-03-01 2011-03-31 2012 Q2 10-Q/A 2012-08-31 0001432093-12-000689
us-gaap SharePrice Share Price USD/shares 0.006 2014-09-30 2014 Q3 10-Q 2014-10-22 0001477932-14-005534
us-gaap ShortTermBankLoansAndNotesPayable Short-term Bank Loans and Notes Payable USD 145,783 2014-09-30 2014 Q3 10-Q 2014-10-22 0001477932-14-005534
us-gaap ShortTermBorrowings Short-term Debt USD 49,227 2010-12-31 2011 Q2 10-Q/A 2011-09-28 0001096350-11-000145
us-gaap ShortTermDebtPercentageBearingFixedInterestRate Short-term Debt, Percentage Bearing Fixed Interest Rate pure 0.05 2013-09-30 2013 Q3 10-Q 2013-11-14 0001477932-13-005415
us-gaap ShortTermNonBankLoansAndNotesPayable Short-term Non-bank Loans and Notes Payable USD 91,716 2013-09-30 2013 Q3 10-Q 2013-11-14 0001477932-13-005415
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -426,232 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap StockIssued1 Stock Issued USD 4,315 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-29 0001477932-17-001354
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 23.22M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-10-22 0001477932-14-005534
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 25,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 383,160 2011-05-01 2011-05-31 2012 Q3 10-Q 2012-11-14 0001471242-12-001449
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 839,951 2011-05-01 2011-05-31 2012 Q2 10-Q/A 2012-08-31 0001432093-12-000689
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 100,000 2013-05-01 2013-05-30 2013 Q2 10-Q 2013-08-02 0001477932-13-003445
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 206,600 2011-10-01 2011-12-31 2011 FY 10-K 2012-05-31 0001214782-12-000044
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD -906 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 11,480 2011-05-01 2011-05-31 2012 Q3 10-Q 2012-11-14 0001471242-12-001449
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 25,669 2011-05-01 2011-05-31 2012 Q2 10-Q/A 2012-08-31 0001432093-12-000689
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 1,410 2013-05-01 2013-05-30 2013 Q2 10-Q 2013-08-02 0001477932-13-003445
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 6,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-29 0001477932-17-001354
us-gaap ValuationAllowanceAmount Valuation Allowance, Amount (Deprecated 2013-01-31) USD -1.17M 2012-12-31 2012 FY 10-K/A 2014-05-05 0001477932-14-002329
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 3.74M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001477932-17-005517

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →